Material Science,Nanomaterials, nanocomposite formulations, pre-dispersed nanomaterials
NanoSperse produces uniformly-dispersed nanointermediates for the defense, aerospace, energy and manufacturing sectors. We custom-blend nanoparticles within a host material to improve thermal, electrical, mechanical and erosion protection properties. We supply these nano-enhanced materials as masterbatches, powders, pellets, thin films, etc. Our products have been qualified to fly on military aircraft. Our capacity is 1 million pounds of nanointermediates per year.
The Faculty of Sciences and Technology (FCT NOVA), Campus of Caparica is one of the most prestigious Portuguese engineering and science public schools and it is engaged in extensive research activity developed in 16 research centres involving 1600 PhD and Master’s students of the total enrolment of 7800.
With a total of 550 academic staff (90% holding a Ph.D) and 180 non-academic staff, FCT NOVA is organized in 14 departments and 14 support services.
FCT NOVA partners with foreign universities such as the Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin to offer some of its advanced study programs. The entrepreneurial drive of the students and graduates of FCT NOVA has led to many successful spin-offs that transfer knowledge to the market and help create value and social impact.
Transparent Conductor Films (TCFs), solution-based inks for the touch sensor and display industry, and Activegrid silver nanowire (AgNW)
Founded in 2010 as a spinout from Professor Zhenan Bao’s chemical engineering laboratory at Stanford University, C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO).
At Innovnano, we manufacture high quality, ultra-fine nanostructured ceramic powders. Established in 2009, we originate from, and are part of, CUF - the largest chemical company in Portugal. Certified by Lloyd's Register Quality Assurance (LRQA) to ISO 9001 standards, we are committed to meeting market demands for top quality products and production processes. And with a new, purpose-built manufacturing technology facility in Coimbra, Portugal, we have a strong technological platform to enable materials production and processing on a large scale. Our unique Emulsion Detonation Synthesis technology is perfectly suited to the industrial-scale production of complex technical ceramic powders and the site capacity of up to 1000 tpa ensures a reliable source of high quality nanostructured ceramic powders for advanced materials applications. Furthermore our EDS process uses feedstock precursors from sustainable sources, ensuring a reliable and economical continuity of supply, and supporting the growth of the nanotechnology industry.
Nanounity supplies surface science analytical solutions through a range of synergistic products through partnerships with leading instrumentation manufacturers. Our core technologies are microscopy, metrology and spectroscopy. Through the strong personal commitment of the founders, Nanounity has built a strong reputation in the USA and Asia providing high standards of materials knowledge enabling the Company to match the requirements of users to a range of tools and techniques. Backed with applications knowledge and customer service support, Nanounity offers experience and skills to help deliver innovative products of the highest performance at affordable prices.
Co-founder and Vice President of Business Development
Nanomerics is a speciality pharmaceutical company focused on the development of pharmaceutical products with enhanced bioavailability. The company uses proprietary pharmaceutical nanotechnology and know-how developed by the founding scientists Professor Ijeoma F. Uchegbu and Dr Andreas G. Schatzlein over the last 14 years at the Universities of Strathclyde and Glasgow and, latterly at the UCL School of Pharmacy. Our scientists have been developing drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. At the heart of the company's offering are polymer based nanomedicines constructed from the self-assembly of amphiphilic polymers and dendrimers.
BlueWillow Biologics is a privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines, based on its patented nanotechnology platform. The company was originally founded as NanoBio Corporation, a spin-off from the Center for Biologic Nanotechnology at the University of Michigan, and was initially focused on developing nano-scale dermatology applications. Based on promising research generated under several Gates Foundation and NIH contracts, the company underwent a strategic “pivot” in 2016–17 to refocus its nanotechnology platform on the development of intranasal vaccines for respiratory and sexually transmitted diseases.
Senior Vice President Vaccine Research and Development
Ali I. Fattom, Ph.D.
Nano Bio Spectroscopy Group (ETSF)
Under the leadership of Professor Angel Rubio, the group activities are focused on the field of theory and modelling of electronic and structural properties in condensed matter and on developing novel theoretical tools and computational codes to investigate the electronic response of solids and nanostructures to external electromagnetic fields. Present research activities are: new developments within many-body theory and TDDFT, including ab-initio description of electron excitations, optical spectroscopy, time-resolved spectroscopies, and lifetimes; novel techniques to calculate total energies and assessment and development of XC functionals for TDDFT calculations; improvements on transport theory within the real-time TDDFT formalism; characterization of the electronic and optical properties of solids, nanostructures (in particular nanotubes, nanowires and semiconducting -clusters-) and biomolecules.
Group-Leader / Full Professor of Condensed Matter Physics
Prof. Angel Rubio
Material Science, Electronic materials
Innova Dynamics is a rapidly-growing, venture capital-backed nanotechnology company serving the touch screen and display industries. This University of Pennsylvania spin-off is commercializing a far reaching materials platform, Innlay, that can transform device performance by embedding nanoparticles directly into the surfaces of polymers and creating new polymer functionalities.
Metrology of graphene and graphene industrial applications, Characterisation of graphene and related 2D materials, International standardisation of graphene and related 2D materials
For more than a century NPL has developed and maintained the nation's primary measurement standards. These standards underpin the National Measurement System infrastructure of traceability throughout the UK and the world that ensures accuracy and consistency of measurement. NPL ensures that cutting-edge measurement science and technology have a positive impact in the real world. NPL delivers world-leading measurement solutions that are critical to commercial research and development, and support business success across the UK and the globe. Good measurement improves productivity and quality; it underpins consumer confidence and trade and is vital to innovation. We undertake research and share our expertise with government, business and society to help enhance economic performance and the quality of life. NPL's measurements help to save lives, protect the environment, enable citizens to feel safe and secure, as well as supporting international trade and companies to innovation. Support in areas such as the development of advanced medical treatments and environmental monitoring helps secure a better quality of life for all. NPL employs over 500 scientists, based in south-west London. Our laboratory is a 36,000 square-metre purpose-built measurement building with 388 of the world's most extensive and sophisticated measurement science laboratories. Visit Publications to view the latest Annual Report and NPL Financial Statements. The Department for Business, Energy and Industrial Strategy (BEIS) owns NPL Management Limited (NPLML) and NPL operates as a public corporation.